AlloVir (ALVR) has provided an announcement.
AlloVir, Inc. has finalized a deal with AMAG Pharmaceuticals, Inc. to terminate a sublease agreement for their Waltham, Massachusetts premises, effective June 30, 2024. The termination comes with the approval of the landlord and involves AlloVir paying a $5.7 million fee, releasing them from further rental obligations post-termination. This strategic move could signal a shift in AlloVir’s operational strategy or financial positioning, which may be of interest to investors monitoring the company’s real estate footprint and cost management efforts.
Find detailed analytics on ALVR stock on TipRanks’ Stock Analysis page.
